Cary Street Partners Investment Advisory LLC Abbott Laboratories Transaction History
Cary Street Partners Investment Advisory LLC
- $2.42 Billion
- Q2 2024
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 65,944 shares of ABT stock, worth $7.41 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
65,944
Previous 57,765
14.16%
Holding current value
$7.41 Million
Previous $6.57 Million
4.37%
% of portfolio
0.28%
Previous 0.28%
Shares
18 transactions
Others Institutions Holding ABT
# of Institutions
3,135Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.36 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.07 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.43 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...